Evidence map›Paper›PMID 41317396›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

An Engineered Solidified Peptide Hemocyte Sponge as Nanomotor Storage to Combat Bacterial Colitis.

Yuxin Fang, Jianming Yan, Tongxin Yu, Zichuan An, Kaikai Lv, Chenyu Xue, Hongyang Yu, Na Dong, Anshan Shan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuxin FangLaboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, P. R. China.
Jianming YanLaboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, P. R. China.
Tongxin YuLaboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, P. R. China.
Zichuan AnLaboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, P. R. China.
Kaikai LvLaboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, P. R. China.
Chenyu XueLaboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, P. R. China.
Hongyang YuDepartment of Radiation Oncology, The Second Affiliated Hospital, Harbin Medical University, Harbin, 150076, P. R. China.
Na DongLaboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, P. R. China.ORCID https://orcid.org/0000-0002-7823-4697
Anshan ShanLaboratory of Molecular Nutrition and Immunity, College of Animal Science and Technology, Northeast Agricultural University, Harbin, 150030, P. R. China.

Funding

Agriculture Research System CARS-35National Key R & D Program of China 2023YFD1301101National Natural Science Foundation of China 32030101National Natural Science Foundation of China U21A20252Science and Technology Innovation Base Award Program of Heilongjiang Province JD24A004Science Fund for Distinguished Young Scholars of Heilongjiang Province JQ2022C002Support Project of Leading Talent Scholar of Northeast Agricultural University NEAU2023QNLJ-017
6 · The paper itself

Abstract

The emergence of drug-resistant bacteria has significantly heightened the urgency for effective interventions within the global public healthcare system. Furthermore, the structural diversity of endotoxins across different bacterial species poses a major limitation on the clearance efficiency of structure-specific anti-endotoxin antibodies. In this study, a peptide-based material with membrane-disrupting functionality is developed. The topological configuration of the peptide is immobilized through Ni

Indexed as

ColitisPeptidesAnimalsEndotoxinsMiceEndotoxinsPeptidesbacterial infectionscellular engineeringendotoxin neutralizationimmobilized antimicrobial peptidesnanomotors

Identifiers

PMID41317396
PMCPMC12884796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.